Received May 21, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
Submitted request to medical regarding a message I received from a clinic that a patient under the age of 10 was given menveo 1 vial instead of menveo two vial. Was told by medical to submit AE form.; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate age at vaccine administration in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced inappropriate age at vaccine administration (Verbatim: Submitted request to medical regarding a message I received from a clinic that a patient under the age of 10 was given menveo 1 vial instead of menveo two vial. Was told by medical to submit AE form.). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK receipt date 12-MAY-2026 The batch number was not provided upon follow up with the reporter.